MEDIROM Healthcare Technologies EBITDA 2021-2025 | MRM
MEDIROM Healthcare Technologies ebitda from 2021 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
MEDIROM Healthcare Technologies Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $2 |
| 2023 | $-1 |
| 2022 | $2 |
| 2021 | $-3 |
| 2020 | $-6 |
| 2019 | |
|
MEDIROM Healthcare Technologies Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | |
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.032B | $0.055B |
| MEDIROM Healthcare Technologies Inc. is a holistic healthcare company. MEDIROM Healthcare Technologies Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |